Investigative Ophthalmology & Visual Science, Vol 29, 1820-1825, Copyright © 1988 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

A peptide from fibronectin cell-binding domain inhibits attachment of epithelial cells

T Nishida, S Nakagawa, K Watanabe, KM Yamada, T Otori and MB Berman
Department of Ophthalmology, Kinki University School of Medicine, Osaka, Japan.

Fibronectin is thought to contribute to the adhesion of corneal epithelium during epithelial repair, presumably by mediating epithelial attachment to stroma during epithelial migration. To understand the mechanism of the interaction of fibronectin with corneal epithelial cells, the effects of intact plasma fibronectin and of the synthetic peptide GRGDS from the cell binding domain of fibronectin on the attachment of rabbit corneal epithelial cells have been examined. When dissociated epithelial cells were plated on fibronectin-coated culture dishes, the number of cells that attached increased in proportion to the concentration of fibronectin used for coating. Attachment of the cells was inhibited in a dose-dependent manner by the addition of GRGDS to the medium. When the structurally similar control peptide GRGES was added to the medium, no inhibition of epithelial attachment was observed. Our results demonstrate that corneal epithelial cells use an adhesive recognition system for fibronectin related to that characterized in fibroblastic cells. GRGDS thus presumably competes for receptors for fibronectin on epithelial cells of the cornea, resulting in the observed inhibition of attachment. These results identify a mechanism for corneal epithelial cell adhesion, compatible with that identified in other fibronectin-dependent systems.

This article has been cited by other articles:

				K. Kimura, A. Hattori, Y. Usui, K. Kitazawa, M. Naganuma, K. Kawamoto, S. Teranishi, M. Nomizu, and T. Nishida Stimulation of Corneal Epithelial Migration by a Synthetic Peptide (PHSRN) Corresponding to the Second Cell-Binding Site of Fibronectin Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1110 - 1118. [Abstract] [Full Text] [PDF]

				P. Chaurasia, J. A. Aguirre-Ghiso, O. D. Liang, H. Gardsvoll, M. Ploug, and L. Ossowski A Region in Urokinase Plasminogen Receptor Domain III Controlling a Functional Association with {alpha}5beta1 Integrin and Tumor Growth J. Biol. Chem., May 26, 2006; 281(21): 14852 - 14863. [Abstract] [Full Text] [PDF]

				M. Watanabe, W. Yano, S. Kondo, Y. Hattori, N. Yamada, R. Yanai, and T. Nishida Up-Regulation of Urokinase-Type Plasminogen Activator in Corneal Epithelial Cells Induced by Wounding Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3332 - 3338. [Abstract] [Full Text] [PDF]

				K. Larouche, S. Leclerc, C. Salesse, and S. L. Guerin Expression of the alpha 5 Integrin Subunit Gene Promoter Is Positively Regulated by the Extracellular Matrix Component Fibronectin through the Transcription Factor Sp1 in Corneal Epithelial Cells in Vitro J. Biol. Chem., December 8, 2000; 275(50): 39182 - 39192. [Abstract] [Full Text] [PDF]